The CoAGulation Biomarkers and Atrial Fibrillation (COAG-AF) Pilot Study
Part of paid clinical trials in New Orleans, Louisiana.
- Sponsor
- Tulane University
- Study ID
- NCT04947657
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 120 Years
- Healthy Volunteers
- Not accepted
Study Details
The aim of the Correlation Of CoAGulation-Atrial Fibrillation (COAG-AF) study is to prove that an increase in pro-thrombotic biomarkers in AF is associated with an increase in AF burden. Secondary objectives of the study are the following: * To investigate the impact of catheter ablation on serum pro-thrombotic biomarkers in patients with AF. * To correlate coagulation biomarkers with imaging features such as, the degree of fibrosis found on Late Gadolinium Enhancement Magnetic Resonance Imaging (LGE-MRI) scans, which is a part of standard of care. * To determine baseline values of coagulation and pro-thrombotic biomarkers in the AF population and compare those baseline values with the general population values. * To compare central and peripheral thrombotic biomarkers in patients with atrial fibrillation.
Key Dates
- Start date
- Sep 22, 2021
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 20 participants (estimated)
Primary Outcome Measure
Measure the change in Asymmetric dimethyl arginine (ADMA) in relation to atrial fibrillation burden [ Time Frame: Day 0, Day 1, Day 2, Day 30, Day 90 ]
Central Contacts
- Mayana Bsoul, MD504-988-3063
- Kunal Sameer, MD, MHA504-988-3072
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| East Jefferson General Hospital | New Orleans | Louisiana | 70006 | Amitabh Pandey, MD (PRINCIPAL_INVESTIGATOR) |
| Tulane Doctors - Speciality Care - Napoleon | New Orleans | Louisiana | 70115 | Amitabh Pandey, MD (PRINCIPAL_INVESTIGATOR) |
| University Medical Center | New Orleans | Louisiana | 70112 | Amitabh Pandey, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New Orleans, LA
Related Studies
- Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPHASE3 · Recruiting · Yale University · Birmingham, Alabama
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- Tulane iPredict, Prevent Study to Evaluate the Progression of Atrial Myopathy.Recruiting · Tulane University School of Medicine · New Orleans, Louisiana
- Atrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot StudyRecruiting · Tulane University · New Orleans, Louisiana